RxDoctor Payments DataLook up a doctor →

Karelia Ruiz

Internal Medicine · Hialeah, FLNPI 1508864356

Payments from drug & device makers

$7,704,644in general payments, 2019–2025

Across 721 payments — averaging $10,686 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$6.7M
  • Applied Therapeutics, Inc.$672K
  • Astrazeneca UK Limited$212K
  • Novartis$104K
  • First Wave Biopharma, Inc.$11K
  • Teva Pharmaceuticals USA, Inc.$9K
  • plus $11K from 36 others
$96,914in research payments, 2019–2025

Across 10 payments — averaging $9691.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • First Wave Biopharma, Inc.$97K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen48$6,685,830
Applied Therapeutics, Inc.68$672,465
Astrazeneca UK Limited8$211,898
Novartis20$103,964
First Wave Biopharma, Inc.1$10,859
Teva Pharmaceuticals USA, Inc.1$8,820
Novo Nordisk72$1,388
GSK66$1,359
Lilly USA, LLC65$976
AstraZeneca46$844
Boehringer Ingelheim29$562
Sanofi-aventis U.S. LLC32$560
AbbVie(2 entities)33$524
Sumitomo Pharma America, Inc.21$483
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$478
Astellas Pharma US Inc21$464
Kowa Pharmaceuticals America, Inc.28$444
Amneal Pharmaceuticals LLC22$386
Johnson & Johnson20$360
Merck17$349
Exact Sciences12$251
Amarin Pharma, Inc.10$183
Heartflow, Inc.2$163
Bayer7$157
Pfizer7$142
Xeris Pharmaceuticals, Inc.6$111
Sunovion Pharmaceuticals Inc.5$105
Radius Health, Inc.5$98
Inspire Medical Systems, Inc.2$73
Esperion Therapeutics, Inc.3$66
Dexcom, Inc.2$34
Sanofi Pasteur Inc.2$33
Ironwood Pharmaceuticals, Inc2$31
Medicure Pharma Inc.1$31
Nabriva Therapeutics, PLC2$30
Phathom Pharmaceuticals, Inc.1$26
Abbott1$18
Dermira, Inc.1$17
Smith+Nephew1$17
Arbor Pharmaceuticals, Inc.1$16
Idorsia Pharmaceuticals US Inc1$16
IBSA Pharma Inc.1$12

How this compares

$7,704,644 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$146,215
Medicare patients
102
Services billed
2,229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Hialeah

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →